Effectiveness of A Stigma Directed Interventional Program in Schizophrenia
1 other identifier
interventional
80
1 country
1
Brief Summary
randomized controlled study measuring the effectiveness of Stigma focused intervention in patients suffering from Schizophrenia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Apr 2019
Longer than P75 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2019
CompletedFirst Submitted
Initial submission to the registry
April 24, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2024
CompletedJuly 10, 2025
July 1, 2025
5.2 years
April 24, 2019
July 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
change in Self-Stigma using the Arabic version of the internalized stigma of mental illness scale
stigma as experienced by patients themselves
Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment
change in perceived family burden using the perceived family burden scale
how much the disorder represent a burden on family
Baseline assessment---- followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment
change in medication adherence using customized chart for each patient
the degree the patient adhere to the prescribed medications
Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) fFinal assessment after 3 months from point 1 Assessment
Secondary Outcomes (1)
change in the clinical outcome using Positive and Negative Symptoms Scale
Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment
Study Arms (2)
study group
EXPERIMENTALIn the study group, both patients and their family members will be required to attend a weekly 1 hour long psycho-educational sessions. Moreover assessment sessions will be attended also. "The stigma directed intervention program"
control group
OTHERIn the control group, only Patients will attend the psycho-educational sessions. Family members and patients will be required to attend the assessment sessions.
Interventions
psycho-educational intervention with emphasis on Stigma
Eligibility Criteria
You may qualify if:
- Patients meet the diagnosis of schizophrenia or schizoaffective disorder according to DSM5.The clinical condition is stabilized.
- Age range between 18 to 50 years.
- Male and female sexes are included.
- Availability of close relative in direct contact with the patient.
- Primary caregiver and the family member share household with patient.
- No history of receiving treatment of psychiatric disorders.
- No history of serious head trauma.
You may not qualify if:
- Co morbid substance abuse or dependence disorder.
- Co morbid intellectual disability.
- Co morbid chronic medical or neurological condition or history of serious head trauma.
- Sever physical illness that hinders their participation- -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mansoura Universitylead
- University of Pittsburghcollaborator
Study Sites (1)
Mansoura University Psychiatry Department
Al Mansurah, Dakahlya, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Vishwaijt Nimgaonkar, PhD
Pittsburgh university
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- the outcome will be assessed by a different personnel than the investigator conducting the sessions of the intervention. The outcomes assessor will be blinded to which arm each participant belongs.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Local Principal Investigator
Study Record Dates
First Submitted
April 24, 2019
First Posted
April 29, 2019
Study Start
April 16, 2019
Primary Completion
June 30, 2024
Study Completion
November 2, 2024
Last Updated
July 10, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share